The role of radiotherapy in MPNST and the impact of NF1 status on outcomes: Insights from a multicenter cohort study
Neuro-Oncology · 2025
DOI: 10.1093/neuonc/noaf186 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Christianne Y M N Jansma und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, University Medical Center Utrecht, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Neurofibromatosis 1, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Malignant peripheral nerve sheath tumors (MPNSTs) are rare, aggressive sarcomas, with 40% associated with neurofibromatosis type 1 (NF1). Surgical excision is the main treatment for localized disease; however, local recurrence (LR) remains high. Radiotherapy (RTx) is increasingly used to enhance local control in STS, but its use remains controversial due to the potential for increased major wound complications and an increased risk of secondary malignancies in NF1 patients. This study investigated the use and impact of RTx on local control in MPNSTs, particularly in the NF1 setting.
Methods
Surgically treated primary MPNSTs from 1988 to 2019 in the MONACO multicenter cohort were included. Differences in demographics, treatment, and RTx use between NF1 and non-NF1 cases were examined. Factors influencing RTx administration and LR were assessed via multivariable analyses.
Results
Among 499 patients (33.1% NF1), 143 (28.7%) experienced LRs. Radiotherapy was administered to 56.3% of patients (57.0% in the NF1 group), with 27.3% receiving neoadjuvant and 72.7% adjuvant RTx. RTx was administered significantly more often to high-grade and extremity tumors. While RTx did not affect overall survival, it reduced LR risk in sporadic cases (hazard ratio [HR] 0.530; 95% confidence interval [CI], 0.354–0.793) but not in the NF1 subgroup (HR 1.00; 95% CI, 0.545–1.85). In NF1 patients, a microscopically positive margin (R1) was the only risk factor for LR development (HR 2.1; 95% CI, 1.19–3.79).
Conclusions
RTx is frequently used in the treatment of MPNSTs, regardless of NF1 status. While it may affect the LR rate in sporadic cases, its impact on NF1 patients is less clear.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Plastic and Reconstructive Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
- Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
- Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Neurosurgery, University Medical Center Utrecht, Utrecht, The Netherlands.
- Department of Surgical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
- Department of Surgical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
ORCID-Profile: Christianne Y M N Jansma, Martinus P G Broen, J Henk Coert, Cornelis Verhoef, Walter Taal
Zitieren
APA
Jansma, C. Y. M. N., Grünhagen, D. J., Flucke, U. E., Slooff, W. M., van Dalen, T., Been, L. B., Bonenkamp, H. J., Anten, M. H. M. E., Broen, M. P. G., Bemelmans, M. H. A., Bramer, J. A. M., Schaap, G. R., Kievit, A. J., van Houdt, W. J., van der Hage, J., van de Sande, M. A. J., Pendleton, C., Spinner, R. J., Coert, J. H., …, & Martin, E. (2025). The role of radiotherapy in MPNST and the impact of NF1 status on outcomes: Insights from a multicenter cohort study. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf186
Vancouver
Jansma CYMN, Grünhagen DJ, Flucke UE, Slooff WM, van Dalen T, Been LB, et al. The role of radiotherapy in MPNST and the impact of NF1 status on outcomes: Insights from a multicenter cohort study. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf186
BibTeX
@article{Jansma2025,
author = {Jansma, Christianne Y M N and Grünhagen, Dirk J and Flucke, Uta E and Slooff, Willem-Bart M and van Dalen, Thijs and Been, Lukas B and Bonenkamp, Han J and Anten, Monique H M E and Broen, Martinus P G and Bemelmans, Marc H A and Bramer, Jos A M and Schaap, Gerard R and Kievit, Arthur J and van Houdt, Winan J and van der Hage, Jos and van de Sande, Michiel A J and Pendleton, Courtney and Spinner, Robert J and Coert, J Henk and Verhoef, Cornelis and Taal, Walter and Martin, Enrico},
title = {The role of radiotherapy in MPNST and the impact of NF1 status on outcomes: Insights from a multicenter cohort study},
journal = {Neuro-Oncology},
year = {2025},
doi = {10.1093/neuonc/noaf186}
}
EUVIMED